Skip to main content
Caplight Logo









Sciessent

Sciessent

Private
Beverly, MassachusettsFrontier & Industrial Techhttps://www.sciessent.com/

Last Round

M&A

Feb 23, 2011

Total Funding Raised

$6.19M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Sciessent is a materials science company that provides antimicrobial, anti-odor, and water repellent solutions for the healthcare, industrial, and consumer goods industries.

Sector

Frontier & Industrial Tech

Verticals

Advanced Materials, Medical Devices, Sustainable Materials, Water Treatment, Fashion & Beauty

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

antimicrobial technologyspecialty chemical additivesodor controldurable water repellentDWRperformance textileszeolite technologythermoregulationsurface treatmentsmaterial sciencePFC-freeanti-pillingsmart fabricsfunctional finishingtextile chemistry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sciessent Comparables

Compare Sciessent with similar companies based on industry and business-model similarity.

Sciessent comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Noble Biomaterials, Inc.
86%
BioCote Limited
83%
Cupron Performance Additives
83%

Sciessent Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AFeb 23, 2011
Series CJan 7, 2005
Private PlacementJan 28, 2003

Sciessent Investors

Notable investors and investment history

Sciessent investors
InvestorRounds
Motorola Solutions Venture CapitalSeries C
Paladin Capital GroupPrivate Placement, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors grew 90% MoM.

  • Nov 6, 2025

    Monthly visitors increased 58% MoM.

Sciessent Filings

Explore SEC and related filing metadata, where available.

Sciessent filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Sciessent's valuation, stock price, and market status.

Is Sciessent a public or private company?

Sciessent is a private company.

What is the current stock price of Sciessent?

Sciessent is a private company with no public stock price. Caplight tracks Sciessent's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Sciessent worth (valuation)?

Valuation information for Sciessent is not publicly available.

Can I buy Sciessent stock?

Sciessent shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Sciessent's last funding round?

Sciessent's most recent funding round was M&A on February 23, 2011.

Who are the main investors in Sciessent?

Key investors in Sciessent include Motorola Solutions Venture Capital, Paladin Capital Group.

Will Sciessent IPO soon?

No public IPO plans have been announced for Sciessent.

How can I track Sciessent secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sciessent's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeverly, Massachusetts
Employee Range28
Year Founded1999
Last FundingFeb 23, 2011

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?